Tyrosine Kinase


Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A4475 TLQP 21Summary: VGF-derived peptide -
A4513 Lestaurtinib1 CitationSummary: JAK2/FLT3/TrkA inhibitor -
B3383 DDR1-IN-1Summary: selective DDR1 receptor tyrosine kinase inhibitor -
B3605 GNE-7915Target: LRRK2Summary: Potent and selective LRRK2 inhibitor -
B3608 Crizotinib hydrochlorideSummary: inhibitor of the c-Met kinase and the NPM-ALK -
A4145 TG101209Summary: JAK2/3 inhibitor -
A4116 Danusertib (PHA-739358)2 CitationTarget: Aurora KinasesSummary: Pan-aurora kinase inhibitor -
A4123 KW 2449Target: Aurora Kinases|FLT3|Bcr-AblSummary: Multikinase inhibitor -
A4237 Amuvatinib (MP-470, HPK 56)Summary: Tyrosine kinase inhibitor -
A3145 Afatinib dimaleateTarget: EGFR|HER2Summary: EGFR inhibitor

